Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Starway Pharm is a China-based pharmaceutical supply and distribution company focused on active pharmaceutical ingredients, finished dosage products, biological drugs, vitamins, enzymes, veterinary products, and feed additives. Publicly available company descriptions position it primarily as a commercial pharmaceutical raw-material distributor and producer rather than a clinical-stage drug developer. Its offerings appear to include regulatory support such as DMF and GMP documentation for customer registrations. Available sources also describe product exposure across anti-cancer, cardiovascular, hormone, antidiabetic, contraceptive, and immunosuppressive categories. Overall, the company appears to operate as a commercial pharma supply-chain participant with broad product coverage rather than a pipeline-driven biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Starway.